The cross-sectional and longitudinal relationship of diabetic retinopathy to cognitive impairment: a systematic review and meta-analysis

To establish a potential relationship between diabetic retinopathy (DR) and different stages of cognitive impairment METHODS: Literature searches were conducted on PubMed and EMBASE, with keywords "diabetic retinopathy" and "cognitive impairment". Inclusion criteria were original...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Eye (London) Ročník 37; číslo 2; s. 220 - 227
Hlavní autoři: Chan, Robert N F, Tang, Ziqi, Chan, Victor T T, Chan, Raymond N C, Cheng, Esther T W, Ng, Natalie C Y, Cheung, Carol Y
Médium: Journal Article
Jazyk:angličtina
Vydáno: England Nature Publishing Group 01.02.2023
Témata:
ISSN:0950-222X, 1476-5454, 1476-5454
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Abstract To establish a potential relationship between diabetic retinopathy (DR) and different stages of cognitive impairment METHODS: Literature searches were conducted on PubMed and EMBASE, with keywords "diabetic retinopathy" and "cognitive impairment". Inclusion criteria were original human studies, and English language. Quality of studies was assessed by the Newcastle-Ottawa Quality Assessment (NOSGEN). The register number of this study on the International Prospective Register of Systematic Reviews (PROSPERO) is CRD42021236747. The main outcome measures were odds ratios (OR) and risk ratios (RR) for cross-sectional and longitudinal studies, respectively. Meta-regression was performed to evaluate the effects of potential moderator variables, including, age, onset age of diabetes mellitus (DM), duration of DM, and HbA1c. Twenty-five studies (17 cross-sectional and 8 longitudinal studies) with a total of 1,963,914 subjects, were included. Among the cross-sectional studies, the pooled ORs of any cognitive impairment, early stage of cognitive impairment and dementia in subjects with DR (95% confidence interval) were 1.48 (1.08-2.02), 1.59 (1.01-2.51), and 1.13 (0.86-1.50), respectively. Among the longitudinal studies, the pooled RRs of any cognitive impairment, early stage of cognitive impairment, and dementia in subjects with DR (95% confidence interval) were 1.35 (1.12-1.65), 1.50 (1.06-2.12), and 1.31 (1.03-1.66), respectively. Meta-regression showed age, onset age of DM, duration of DM, and glycated hemoglobin (HbA1c) were not statistically associated with the outcomes. The presence of DR in DM patients indicates both higher odds of prevalent cognitive impairment and escalated risks of developing cognitive impairment in the future.
AbstractList To establish a potential relationship between diabetic retinopathy (DR) and different stages of cognitive impairment METHODS: Literature searches were conducted on PubMed and EMBASE, with keywords "diabetic retinopathy" and "cognitive impairment". Inclusion criteria were original human studies, and English language. Quality of studies was assessed by the Newcastle-Ottawa Quality Assessment (NOSGEN). The register number of this study on the International Prospective Register of Systematic Reviews (PROSPERO) is CRD42021236747. The main outcome measures were odds ratios (OR) and risk ratios (RR) for cross-sectional and longitudinal studies, respectively. Meta-regression was performed to evaluate the effects of potential moderator variables, including, age, onset age of diabetes mellitus (DM), duration of DM, and HbA1c. Twenty-five studies (17 cross-sectional and 8 longitudinal studies) with a total of 1,963,914 subjects, were included. Among the cross-sectional studies, the pooled ORs of any cognitive impairment, early stage of cognitive impairment and dementia in subjects with DR (95% confidence interval) were 1.48 (1.08-2.02), 1.59 (1.01-2.51), and 1.13 (0.86-1.50), respectively. Among the longitudinal studies, the pooled RRs of any cognitive impairment, early stage of cognitive impairment, and dementia in subjects with DR (95% confidence interval) were 1.35 (1.12-1.65), 1.50 (1.06-2.12), and 1.31 (1.03-1.66), respectively. Meta-regression showed age, onset age of DM, duration of DM, and glycated hemoglobin (HbA1c) were not statistically associated with the outcomes. The presence of DR in DM patients indicates both higher odds of prevalent cognitive impairment and escalated risks of developing cognitive impairment in the future.
To establish a potential relationship between diabetic retinopathy (DR) and different stages of cognitive impairment METHODS: Literature searches were conducted on PubMed and EMBASE, with keywords "diabetic retinopathy" and "cognitive impairment". Inclusion criteria were original human studies, and English language. Quality of studies was assessed by the Newcastle-Ottawa Quality Assessment (NOSGEN). The register number of this study on the International Prospective Register of Systematic Reviews (PROSPERO) is CRD42021236747. The main outcome measures were odds ratios (OR) and risk ratios (RR) for cross-sectional and longitudinal studies, respectively. Meta-regression was performed to evaluate the effects of potential moderator variables, including, age, onset age of diabetes mellitus (DM), duration of DM, and HbA1c.OBJECTIVESTo establish a potential relationship between diabetic retinopathy (DR) and different stages of cognitive impairment METHODS: Literature searches were conducted on PubMed and EMBASE, with keywords "diabetic retinopathy" and "cognitive impairment". Inclusion criteria were original human studies, and English language. Quality of studies was assessed by the Newcastle-Ottawa Quality Assessment (NOSGEN). The register number of this study on the International Prospective Register of Systematic Reviews (PROSPERO) is CRD42021236747. The main outcome measures were odds ratios (OR) and risk ratios (RR) for cross-sectional and longitudinal studies, respectively. Meta-regression was performed to evaluate the effects of potential moderator variables, including, age, onset age of diabetes mellitus (DM), duration of DM, and HbA1c.Twenty-five studies (17 cross-sectional and 8 longitudinal studies) with a total of 1,963,914 subjects, were included. Among the cross-sectional studies, the pooled ORs of any cognitive impairment, early stage of cognitive impairment and dementia in subjects with DR (95% confidence interval) were 1.48 (1.08-2.02), 1.59 (1.01-2.51), and 1.13 (0.86-1.50), respectively. Among the longitudinal studies, the pooled RRs of any cognitive impairment, early stage of cognitive impairment, and dementia in subjects with DR (95% confidence interval) were 1.35 (1.12-1.65), 1.50 (1.06-2.12), and 1.31 (1.03-1.66), respectively. Meta-regression showed age, onset age of DM, duration of DM, and glycated hemoglobin (HbA1c) were not statistically associated with the outcomes.RESULTSTwenty-five studies (17 cross-sectional and 8 longitudinal studies) with a total of 1,963,914 subjects, were included. Among the cross-sectional studies, the pooled ORs of any cognitive impairment, early stage of cognitive impairment and dementia in subjects with DR (95% confidence interval) were 1.48 (1.08-2.02), 1.59 (1.01-2.51), and 1.13 (0.86-1.50), respectively. Among the longitudinal studies, the pooled RRs of any cognitive impairment, early stage of cognitive impairment, and dementia in subjects with DR (95% confidence interval) were 1.35 (1.12-1.65), 1.50 (1.06-2.12), and 1.31 (1.03-1.66), respectively. Meta-regression showed age, onset age of DM, duration of DM, and glycated hemoglobin (HbA1c) were not statistically associated with the outcomes.The presence of DR in DM patients indicates both higher odds of prevalent cognitive impairment and escalated risks of developing cognitive impairment in the future.CONCLUSIONSThe presence of DR in DM patients indicates both higher odds of prevalent cognitive impairment and escalated risks of developing cognitive impairment in the future.
ObjectivesTo establish a potential relationship between diabetic retinopathy (DR) and different stages of cognitive impairmentMethodsLiterature searches were conducted on PubMed and EMBASE, with keywords “diabetic retinopathy” and “cognitive impairment”. Inclusion criteria were original human studies, and English language. Quality of studies was assessed by the Newcastle-Ottawa Quality Assessment (NOSGEN). The register number of this study on the International Prospective Register of Systematic Reviews (PROSPERO) is CRD42021236747. The main outcome measures were odds ratios (OR) and risk ratios (RR) for cross-sectional and longitudinal studies, respectively. Meta-regression was performed to evaluate the effects of potential moderator variables, including, age, onset age of diabetes mellitus (DM), duration of DM, and HbA1c.ResultsTwenty-five studies (17 cross-sectional and 8 longitudinal studies) with a total of 1,963,914 subjects, were included. Among the cross-sectional studies, the pooled ORs of any cognitive impairment, early stage of cognitive impairment and dementia in subjects with DR (95% confidence interval) were 1.48 (1.08–2.02), 1.59 (1.01–2.51), and 1.13 (0.86–1.50), respectively. Among the longitudinal studies, the pooled RRs of any cognitive impairment, early stage of cognitive impairment, and dementia in subjects with DR (95% confidence interval) were 1.35 (1.12–1.65), 1.50 (1.06–2.12), and 1.31 (1.03–1.66), respectively. Meta-regression showed age, onset age of DM, duration of DM, and glycated hemoglobin (HbA1c) were not statistically associated with the outcomes.ConclusionsThe presence of DR in DM patients indicates both higher odds of prevalent cognitive impairment and escalated risks of developing cognitive impairment in the future.
Author Cheng, Esther T W
Ng, Natalie C Y
Chan, Raymond N C
Chan, Robert N F
Cheung, Carol Y
Tang, Ziqi
Chan, Victor T T
Author_xml – sequence: 1
  givenname: Robert N F
  surname: Chan
  fullname: Chan, Robert N F
  organization: Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, Hong Kong, China
– sequence: 2
  givenname: Ziqi
  surname: Tang
  fullname: Tang, Ziqi
  organization: Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, Hong Kong, China
– sequence: 3
  givenname: Victor T T
  surname: Chan
  fullname: Chan, Victor T T
  organization: Department of Ophthalmology and Visual Sciences, Prince of Wales Hospital, Hong Kong Special Administrative Region, Hong Kong, China
– sequence: 4
  givenname: Raymond N C
  surname: Chan
  fullname: Chan, Raymond N C
  organization: Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, Hong Kong, China
– sequence: 5
  givenname: Esther T W
  surname: Cheng
  fullname: Cheng, Esther T W
  organization: Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, Hong Kong, China
– sequence: 6
  givenname: Natalie C Y
  surname: Ng
  fullname: Ng, Natalie C Y
  organization: Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, Hong Kong, China
– sequence: 7
  givenname: Carol Y
  surname: Cheung
  fullname: Cheung, Carol Y
  email: carolcheung@cuhk.edu.hk
  organization: Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, Hong Kong, China. carolcheung@cuhk.edu.hk
BackLink https://www.ncbi.nlm.nih.gov/pubmed/35501601$$D View this record in MEDLINE/PubMed
BookMark eNpdkMlO5EAMhkuIETTLC3BAJXHhkhnXmoQbQswiIc2FkebWclIOXSipCqlKo36DeewJ24WDZcv_59-Wj9h-iIEYOxPwVYCqviUttFIFSLkELJXcYyuhS1sYbfQ-W0FtoJBS_j1kRyk9AixiCQfsUBkDwoJYsX_3G-LtFFMqErXZx4A9x-B4H8ODz7PzL42JenzR0saPPHbceWwo-3YRsg9xxLzZ8Rx5Gx-Cz35L3A8j-mmgkK848rRLmQZ8m9h6en5dMVDGAhf_XfLphH3psE90-p6P2Z_vt_c3P4u73z9-3VzfFa0udS40SacBKuzIVdYAQWPR1qKRHZTOuaoBcCipKZWRqLV1rbKlajojagQh1TG7fPMdp_g0U8rrwaeW-h4DxTmtpTW1lJWxakEvPqGPcZ6WexeqtFWthXk1PH-n5mYgtx4nP-C0W3_8WP0H6hiC0A
CitedBy_id crossref_primary_10_1155_jdr_8029913
crossref_primary_10_5014_ajot_2025_050631
crossref_primary_10_1016_j_jamda_2023_06_025
crossref_primary_10_1080_13607863_2023_2226616
crossref_primary_10_1016_j_arr_2024_102523
crossref_primary_10_1016_j_preteyeres_2024_101290
crossref_primary_10_1007_s40200_023_01381_4
crossref_primary_10_1177_13872877251378759
crossref_primary_10_1007_s11682_025_01029_2
crossref_primary_10_32674_afxxt759
ContentType Journal Article
Copyright 2022. The Author(s), under exclusive licence to The Royal College of Ophthalmologists.
The Author(s), under exclusive licence to The Royal College of Ophthalmologists 2022.
Copyright_xml – notice: 2022. The Author(s), under exclusive licence to The Royal College of Ophthalmologists.
– notice: The Author(s), under exclusive licence to The Royal College of Ophthalmologists 2022.
DBID CGR
CUY
CVF
ECM
EIF
NPM
3V.
7TK
7X7
7XB
88E
8AO
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M1P
M7P
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
7X8
DOI 10.1038/s41433-022-02033-2
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Neurosciences Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
ProQuest SciTech Collection
ProQuest Natural Science Journals
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
ProQuest Health & Medical Collection
Medical Database
Biological Science Database
ProQuest Central Premium
ProQuest One Academic
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic (retired)
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central China
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic
ProQuest Central Student
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1476-5454
EndPage 227
ExternalDocumentID 35501601
Genre Meta-Analysis
Systematic Review
Journal Article
GroupedDBID ---
-Q-
.GJ
0R~
29G
2WC
36B
39C
3O-
4.4
406
53G
5RE
6PF
70F
7X7
88E
8AO
8FI
8FJ
8R4
8R5
AACDK
AANZL
AASML
AATNV
AAWTL
AAYZH
ABAKF
ABAWZ
ABBRH
ABCQX
ABDBE
ABFSG
ABJNI
ABLJU
ABRTQ
ABUWG
ABZZP
ACAOD
ACGFS
ACKTT
ACPRK
ACRQY
ACSTC
ACZOJ
ADBBV
AEFQL
AEJRE
AEMSY
AENEX
AEVLU
AEXYK
AEZWR
AFBBN
AFDZB
AFFNX
AFHIU
AFKRA
AFSHS
AGAYW
AGHAI
AGQEE
AHMBA
AHSBF
AHWEU
AIGIU
AILAN
AIXLP
AJRNO
ALFFA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMYLF
AOIJS
ATHPR
AXYYD
AYFIA
BAWUL
BBNVY
BENPR
BHPHI
BKKNO
BPHCQ
BVXVI
CAG
CCPQU
CGR
COF
CS3
CUY
CVF
DIK
DNIVK
DPUIP
E3Z
EBLON
EBS
EBX
ECM
EE.
EIF
EIOEI
EJD
EMB
EMOBN
F5P
FDQFY
FERAY
FIGPU
FIZPM
FSGXE
FYUFA
GX1
HCIFZ
HMCUK
HYE
HZ~
IWAJR
JSO
JZLTJ
KQ8
L7B
M1P
M7P
NPM
NQJWS
O9-
OK1
P2P
PHGZM
PHGZT
PJZUB
PPXIY
PQGLB
PQQKQ
PROAC
PSQYO
Q2X
RNS
RNT
RNTTT
ROL
RPM
SNX
SNYQT
SOHCF
SOJ
SRMVM
SV3
SWTZT
TAOOD
TBHMF
TDRGL
TR2
UKHRP
W2D
ZGI
ZXP
3V.
7TK
7XB
8FE
8FH
8FK
AZQEC
DWQXO
GNUQQ
K9.
LK8
PKEHL
PQEST
PQUKI
PRINS
7X8
ID FETCH-LOGICAL-c474t-4e2d4008afed8650e0b6a691b2f07ddd8b00da2eb7352a446dc3673bf519a0123
IEDL.DBID M7P
ISICitedReferencesCount 12
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000789783800001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 0950-222X
1476-5454
IngestDate Sun Nov 09 13:38:28 EST 2025
Mon Oct 06 17:44:19 EDT 2025
Mon Jul 21 06:06:29 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Language English
License 2022. The Author(s), under exclusive licence to The Royal College of Ophthalmologists.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c474t-4e2d4008afed8650e0b6a691b2f07ddd8b00da2eb7352a446dc3673bf519a0123
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
content type line 14
ObjectType-Feature-3
ObjectType-Evidence Based Healthcare-1
ObjectType-Feature-1
ObjectType-Review-4
content type line 23
ObjectType-Undefined-3
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/9873601
PMID 35501601
PQID 2768941512
PQPubID 33647
PageCount 8
ParticipantIDs proquest_miscellaneous_2659228563
proquest_journals_2768941512
pubmed_primary_35501601
PublicationCentury 2000
PublicationDate 2023-02-01
PublicationDateYYYYMMDD 2023-02-01
PublicationDate_xml – month: 02
  year: 2023
  text: 2023-02-01
  day: 01
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle Eye (London)
PublicationTitleAlternate Eye (Lond)
PublicationYear 2023
Publisher Nature Publishing Group
Publisher_xml – name: Nature Publishing Group
SSID ssj0014770
Score 2.4274027
SecondaryResourceType review_article
Snippet To establish a potential relationship between diabetic retinopathy (DR) and different stages of cognitive impairment METHODS: Literature searches were...
ObjectivesTo establish a potential relationship between diabetic retinopathy (DR) and different stages of cognitive impairmentMethodsLiterature searches were...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 220
SubjectTerms Age
Cognition
Cognitive ability
Confidence intervals
Cross-Sectional Studies
Dementia
Dementia - complications
Dementia disorders
Diabetes
Diabetes mellitus
Diabetes Mellitus, Type 2 - complications
Diabetic retinopathy
Diabetic Retinopathy - complications
Glycated Hemoglobin
Hemoglobin
Humans
Longitudinal studies
Meta-analysis
Quality control
Retinopathy
Risk Factors
Title The cross-sectional and longitudinal relationship of diabetic retinopathy to cognitive impairment: a systematic review and meta-analysis
URI https://www.ncbi.nlm.nih.gov/pubmed/35501601
https://www.proquest.com/docview/2768941512
https://www.proquest.com/docview/2659228563
Volume 37
WOSCitedRecordID wos000789783800001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1NTxsxEB1BqCouBUrLRyFypV4tNl4n9nJBFIF6gChCBeUWede2iAS7aXaDxD_gZ3fG64RTufTiy1reldfjefabmQfwQ1in-9IW3OdWctmzGTeF01z5nhNELCUhy_X-Wg2HejzORvHCrY5hlcs9MWzUtirojvxEIC7OJPmns9kfTqpRxK5GCY112KAqCWkI3RutWASpglgcooiEox8cx6SZJNUntUSgQAym4MTFpVz8G2IGV3O19b8fuQ2fIshk5-2q2IE1V36GjzeRRt-FV1wcLPhHXodQLOptSsseK5IvWliSymLzZZzcw3TGKs_aa9ppwSjxsaxIy_iFNRVbRSAxSrmczum-8ZQZ9lYkmrUJMuEVT64x3MRSKF_g7ury98UvHiUZeCGVbLh0wqLVa-Od1QjuXJIPzCDr5cInylqr0YqtES5XCOwMHjVtkQ5UmnsEiobg21folFXp9oFRrcAs8V7hmUl6qXTRdwoRA44v-z5JD-BoOceTaFf15G2CD-D76jFaBNEcpnTVAvsQUyx0f4BD7LX_cTJrS3dMEF1RSb3e4fuDf4NNkpVvo7OPoNPMF-4YPhTPzbSed2FdjVVodRc2fl4OR7fdsPCwHY5u_gKQouCh
linkProvider ProQuest
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB4tBVEu5VX6BIxUjtYmjnftVKoqBFStul1xaNHeghPbYqU22W6yoP0H_Bp-IzN5bE9w64FzrIlkf575xvMCOBDW6YG0GfeplVyGNuYmc5orHzpBgaWgrnL9OlLjsZ5M4i89-N3VwlBaZacTa0Vti4zeyPsCeXEsyT4dz245TY2i6Go3QqOBxblb_kSXrTw6-4Tn-16Ik8-XH095O1WAZ1LJiksnLAJXG--sRn7ignRohnGYCh8oa61GIFojXKqQmxj0lmwWDVWUeuQ6hhgIyn0AD1GPK0ohU5OVgxdKVQ-nQ9YScLS7k7ZIJ4h0v5RITChiKjjF_iIu_k5pa9N28vR_25RnsNGSaPahQf1z6Ln8BTy-aNMEXsIvBD-r7T8v61QzWm1yy64LGs-0sDQKjM27PMDv0xkrPGueoacZo8LOvKBZzUtWFWyVYcWopHQ6p_fUQ2bYXRNs1hQA1b-4cZXhpm31sglX97IPr2AtL3K3DYx6IcaB9wp9Quml0tnAKWREKF8OfBDtwH53pkmrN8rk7kB34N3qM954CuOY3BULXEORcKEHQxSx1eAmmTWtSRJkj9QyMNz9t_C3sH56eTFKRmfj8z14IpC4NZno-7BWzRfuNTzKflTTcv6mBjiDb_cNnj8ERjkG
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Nb9QwEB2VFlW9tOWrHxQwEhytzTretYOEKkRZUbWs9gBob8GJbbFSm2w32Vb9B_wmfh0zTrI9wa0HzrEmkj0eP_u9mQF4I6zTA2lz7jMruezbhJvcaa583wkilqKQ5fr9XI3HejpNJmvwu8uFIVllFxNDoLZlTm_kPYG4OJF0PvV8K4uYnIyO51ecOkgR09q102hc5Mzd3uD1rXp_eoJr_VaI0aevHz_ztsMAz6WSNZdOWHRibbyzGrGKi7KhGSb9TPhIWWs1OqU1wmUKcYrBm5PN46GKM4-4xxAaQbsPYENR0fIgG5ysGAypQqM6RDARxzN42ibsRLHuVRJBCrGnghMPGHPxd3gbjrnRzv88Qbuw3YJr9qHZDY9gzRWPYfNLKx94Ar9wU7CAC3gVJGg02hSWXZTUtmlpqUUYW3T6wJ-zOSs9a56nZzmjhM-ipB7Ot6wu2Up5xSjVdLagd9Z3zLC74tisSQwKv7h0teGmLQHzFL7dyzw8g_WiLNw-MKqRmETeK7wrSi-VzgdOIVJC-3Lgo_gAjrr1Tdt4UqV3i3sAr1efMRIQvWMKVy5xDDHkQg-GaGKv8aF03pQsSRFVUinB_uG_jb-CTfSZ9Px0fPYctgTiuUagfgTr9WLpXsDD_LqeVYuXwdcZ_Lhv3_kDQWpB1A
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+cross-sectional+and+longitudinal+relationship+of+diabetic+retinopathy+to+cognitive+impairment%3A+a+systematic+review+and+meta-analysis&rft.jtitle=Eye+%28London%29&rft.au=Chan%2C+Robert+N.+F&rft.au=Tang%2C+Ziqi&rft.au=Chan%2C+Victor+T.+T&rft.au=Chan%2C+Raymond+N.+C&rft.date=2023-02-01&rft.pub=Nature+Publishing+Group&rft.issn=0950-222X&rft.eissn=1476-5454&rft.volume=37&rft.issue=2&rft.spage=220&rft.epage=227&rft_id=info:doi/10.1038%2Fs41433-022-02033-2&rft.externalDBID=HAS_PDF_LINK
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0950-222X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0950-222X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0950-222X&client=summon